表紙:非侵襲性出生前検査(NIPT)の世界市場 - 業界分析、規模、シェア、成長、動向、予測(2022年~2031年)
市場調査レポート
商品コード
1149277

非侵襲性出生前検査(NIPT)の世界市場 - 業界分析、規模、シェア、成長、動向、予測(2022年~2031年)

Non-invasive Prenatal Testing Market (Test Type: Materni21, Harmony, Panorama, Verifi, NIFTY, and Others; and Technology: NGS, WGS, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 199 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
非侵襲性出生前検査(NIPT)の世界市場 - 業界分析、規模、シェア、成長、動向、予測(2022年~2031年)
出版日: 2022年09月28日
発行: Transparency Market Research
ページ情報: 英文 199 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の非侵襲性出生前検査(NIPT)市場について調査分析し、市場動向、セグメント分析、地域分析、企業プロファイルなどを提供しています。

目次

第1章 序文

第2章 前提と調査手法

第3章 エグゼクティブサマリー:世界の非侵襲性出生前検査(NIPT)市場

第4章 市場の概要

  • イントロダクション
    • 検査タイプの定義
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界の非侵襲性出生前検査(NIPT)市場の分析と予測(2017年~2031年)
    • 市場収益予測

第5章 主な考察

  • 主な業界の進化/発展
  • コスト比較分析
  • NIPTの進歩
  • COVID-19の影響の分析

第6章 世界の非侵襲性出生前検査(NIPT)市場の分析と予測:検査タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額の予測:検査タイプ別(2017年~2031年)
    • Materni21
    • Harmony
    • Panorama
    • Verifi
    • NIFTY
    • その他
  • 市場魅力分析:検査タイプ別

第7章 世界の非侵襲性出生前検査(NIPT)市場の分析と予測:用途別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額の予測:用途別(2017年~2031年)
    • トリソミー
    • 微小欠失症候群
    • その他
  • 市場魅力分析:用途別

第8章 世界の非侵襲性出生前検査(NIPT)市場の分析と予測:技術別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額の予測:技術別(2017年~2031年)
    • NGS
    • WGS
    • その他
  • 市場魅力分析:技術別

第9章 世界の非侵襲性出生前検査(NIPT)市場の分析と予測:エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額の予測:エンドユーザー別(2017年~2031年)
    • 病院
    • 診断研究所
    • その他
  • 市場魅力分析:エンドユーザー別

第10章 世界の非侵襲性出生前検査(NIPT)市場の分析と予測:地域別

  • 主な調査結果
  • 市場金額の予測:地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力分析:地域別

第11章 北米の非侵襲性出生前検査(NIPT)市場の分析と予測

  • イントロダクション
    • 主な調査結果
  • 市場金額の予測:検査タイプ別(2017年~2031年)
  • 市場金額の予測:用途別(2017年~2031年)
  • 市場金額の予測:技術別(2017年~2031年)
  • 市場金額の予測:エンドユーザー別(2017年~2031年)
  • 市場金額の予測:国別(2017年~2031年)
    • 米国
    • カナダ
  • 市場魅力分析
    • 検査タイプ別
    • 用途別
    • 技術別
    • エンドユーザー別
    • 国別

第12章 欧州の非侵襲性出生前検査(NIPT)市場の分析と予測

第13章 アジア太平洋の非侵襲性出生前検査(NIPT)市場の分析と予測

第14章 ラテンアメリカの非侵襲性出生前検査(NIPT)市場の分析と予測

第15章 中東・アフリカの非侵襲性出生前検査(NIPT)市場の分析と予測

第16章 競合情勢

  • 市場企業 - 競合マトリックス:階層・企業規模別
  • 市場シェア分析:企業別(2021年)
  • 企業プロファイル
    • Berry Genetics
    • BGI
    • Laboratory Corporation of America Holdings
    • Agilent Technologies, Inc.
    • Illumina, Inc.
    • F. Hoffmann-La Roche Ltd.
    • PerkinElmer, Inc.
    • Eurofins LifeCodexx AG
    • QIAGEN
    • IGENOMIX
    • Pacific Biosciences
    • Natera, Inc.
図表

List of Tables

  • Table 01: Global Non-invasive Prenatal Testing Market Value Share, by Test Type, 2021
  • Table 02: Global Non-invasive Prenatal Testing Market Value Share, by Application, 2021
  • Table 03: Global Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 04: Global Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 05: Global Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 06: Global Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 07: Global Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 08: North America Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 09: North America Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 10: North America Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 11: North America Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: North America Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 13: Europe Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 14: Europe Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: Europe Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 16: Europe Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Europe Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Asia Pacific Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 19: Asia Pacific Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Asia Pacific Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 21: Asia Pacific Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 22: Asia Pacific Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 23: Latin America Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 24: Latin America Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 25: Latin America Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 26: Latin America Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 27: Latin America Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 28: Middle East & Africa Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Test Type, 2017-2031
  • Table 29: Middle East & Africa Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 30: Middle East & Africa Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Technology, 2017-2031
  • Table 31: Middle East & Africa Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 32: Middle East & Africa Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Non-invasive Prenatal Testing Market Snapshot
  • Figure 02: Global Non-invasive Prenatal Testing Market Segments With Leading Market Share (%), 2021
  • Figure 03: Key Industry Developments (Non-invasive Prenatal Testing Market)
  • Figure 04: Global Non-invasive Prenatal Testing Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 05: Global Non-invasive Prenatal Testing Market Value Share (%), by Test Type (2021)
  • Figure 06: Global Non-invasive Prenatal Testing Market Value Share (%), by Application (2021)
  • Figure 07: Global Non-invasive Prenatal Testing Market Value Share (%), by Technology (2021)
  • Figure 08: Global Non-invasive Prenatal Testing Market Value Share(%), by End-user (2021)
  • Figure 09: Global Non-invasive Prenatal Testing Market Value Share (%), by Region (2021)
  • Figure 10: Global Non-invasive Prenatal Testing Market Value Share Analysis, by Test Type, 2021 and 2031
  • Figure 11: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 12: Global Non-invasive Prenatal Testing Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 13: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 14: Global Non-invasive Prenatal Testing Market Value Share Analysis, by Technology, 2021 and 2031
  • Figure 15: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, by Technology, 2022-2031
  • Figure 16: Global Non-invasive Prenatal Testing Market Value Share(%), by End-user, 2021 and 2031
  • Figure 17: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 18: Global Non-invasive Prenatal Testing Market Value Share Analysis, by Region 2021 and 2031
  • Figure 19: Global Non-invasive Prenatal Testing Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 20: North America Non-invasive Prenatal Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 21: North America Non-invasive Prenatal Testing Market Value Share (%), by Test Type, 2021 and 2031
  • Figure 22: North America Non-invasive Prenatal Testing Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 23: North America Non-invasive Prenatal Testing Market Value Share (%), by Application, 2021 and 2031
  • Figure 24: North America Non-invasive Prenatal Testing Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 25: North America Non-invasive Prenatal Testing Market Value Share (%), by Technology, 2021 and 2031
  • Figure 26: North America Non-invasive Prenatal Testing Market Attractiveness Analysis, by Technology, 2022-2031
  • Figure 27: North America Non-invasive Prenatal Testing Market Share (%), by End-user, 2021 and 2031
  • Figure 28: North America Non-invasive Prenatal Testing Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 29: North America Non-invasive Prenatal Testing Market Value Share (%), by Country, 2021 and 2031
  • Figure 30: North America Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 31: Europe Non-invasive Prenatal Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 32: Europe Non-invasive Prenatal Testing Market Value Share (%), by Test Type, 2021 and 2031
  • Figure 33: Europe Non-invasive Prenatal Testing Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 34: Europe Non-invasive Prenatal Testing Market Value Share (%), by Application, 2021 and 2031
  • Figure 35: Europe Non-invasive Prenatal Testing Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 36: Europe Non-invasive Prenatal Testing Market Value Share (%), by Technology, 2021 and 2031
  • Figure 37: Europe Non-invasive Prenatal Testing Market Attractiveness Analysis, by Technology, 2022-2031
  • Figure 38: Europe Non-invasive Prenatal Testing Market Share (%), by End-user, 2021 and 2031
  • Figure 39: Europe Non-invasive Prenatal Testing Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 40: Europe Non-invasive Prenatal Testing Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 41: Europe Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 42: Asia Pacific Non-invasive Prenatal Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 43: Asia Pacific Non-invasive Prenatal Testing Market Value Share (%), by Test Type, 2021 and 2031
  • Figure 44: Asia Pacific Non-invasive Prenatal Testing Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 45: Asia Pacific Non-invasive Prenatal Testing Market Value Share (%), by Application, 2021 and 2031
  • Figure 46: Asia Pacific Non-invasive Prenatal Testing Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 47: Asia Pacific Non-invasive Prenatal Testing Market Value Share (%), by Technology, 2021 and 2031
  • Figure 48: Asia Pacific Non-invasive Prenatal Testing Market Attractiveness Analysis, by Technology, 2022-2031
  • Figure 49: Asia Pacific Non-invasive Prenatal Testing Market Share (%), by End-user, 2021 and 2031
  • Figure 50: Asia Pacific Non-invasive Prenatal Testing Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 51: Asia Pacific Non-invasive Prenatal Testing Market Attractiveness Analysis, by End-user, 2021 and 2031
  • Figure 52: Asia Pacific Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 53: Latin America Non-invasive Prenatal Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 54: Latin America Non-invasive Prenatal Testing Market Value Share (%), by Test Type, 2021 and 2031
  • Figure 55: Latin America Non-invasive Prenatal Testing Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 56: Latin America Non-invasive Prenatal Testing Market Value Share (%), by Application, 2021 and 2031
  • Figure 57: Latin America Non-invasive Prenatal Testing Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 58: Latin America Non-invasive Prenatal Testing Market Value Share (%), by Technology, 2021 and 2031
  • Figure 59: Latin America Non-invasive Prenatal Testing Market Attractiveness Analysis, by Technology, 2022-2031
  • Figure 60: Latin America Non-invasive Prenatal Testing Market Share (%), by End-user, 2021 and 2031
  • Figure 61: Latin America Non-invasive Prenatal Testing Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 62: Latin America Non-invasive Prenatal Testing Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 63: Latin America Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 64: Middle East & Africa Non-invasive Prenatal Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
  • Figure 65: Middle East & Africa Non-invasive Prenatal Testing Market Value Share (%), by Test Type, 2021 and 2031
  • Figure 66: Middle East & Africa Non-invasive Prenatal Testing Market Attractiveness Analysis, by Test Type, 2022-2031
  • Figure 67: Middle East & Africa Non-invasive Prenatal Testing Market Value Share (%), by Application, 2021 and 2031
  • Figure 68: Middle East & Africa Non-invasive Prenatal Testing Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 69: Middle East & Africa Non-invasive Prenatal Testing Market Value Share (%), by Technology, 2021 and 2031
  • Figure 70: Middle East & Africa Non-invasive Prenatal Testing Market Attractiveness Analysis, by Technology, 2022-2031
  • Figure 71: Middle East & Africa Non-invasive Prenatal Testing Market Share (%), by End-user, 2021 and 2031
  • Figure 72: Middle East & Africa Non-invasive Prenatal Testing Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 73: Middle East & Africa Non-invasive Prenatal Testing Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 74: Middle East & Africa Non-invasive Prenatal Testing Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
目次
Product Code: TMRGL374

The report provides revenue of the global non-invasive prenatal testing market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global non-invasive prenatal testing market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the non-invasive prenatal testing market.

The report delves into the competitive landscape of the global non-invasive prenatal testing market. Key players operating in the global non-invasive prenatal testing market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global non-invasive prenatal testing market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Non-invasive Prenatal Testing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Test Type Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Non-invasive Prenatal Testing Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Evolution/Developments
  • 5.2. Cost Comparison Analysis
  • 5.3. Advancement in NIPT
  • 5.4. Covid 19 Impact Analysis

6. Global Non-invasive Prenatal Testing Market Analysis and Forecast, by Test Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Test Type, 2017-2031
    • 6.3.1. Materni21
    • 6.3.2. Harmony
    • 6.3.3. Panorama
    • 6.3.4. Verifi
    • 6.3.5. NIFTY
    • 6.3.6. Others
  • 6.4. Market Attractiveness Analysis, by Test Type

7. Global Non-invasive Prenatal Testing Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Trisomy
    • 7.3.2. Micro-deletions Symptoms
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Non-invasive Prenatal Testing Market Analysis and Forecast, by Technology

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Technology, 2017-2031
    • 8.3.1. NGS
    • 8.3.2. WGS
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by Technology

9. Global Non-invasive Prenatal Testing Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Laboratories
    • 9.3.3. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Non-invasive Prenatal Testing Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness Analysis, by Region

11. North America Non-invasive Prenatal Testing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Test Type, 2017-2031
    • 11.2.1. Materni21
    • 11.2.2. Harmony
    • 11.2.3. Panorama
    • 11.2.4. Verifi
    • 11.2.5. NIFTY
    • 11.2.6. Others
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Trisomy
    • 11.3.2. Micro-deletions Symptoms
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Technology, 2017-2031
    • 11.4.1. NGS
    • 11.4.2. WGS
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Diagnostic Laboratories
    • 11.5.3. Others
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Test Type
    • 11.7.2. By Application
    • 11.7.3. By Technology
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Non-invasive Prenatal Testing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Test Type, 2017-2031
    • 12.2.1. Materni21
    • 12.2.2. Harmony
    • 12.2.3. Panorama
    • 12.2.4. Verifi
    • 12.2.5. NIFTY
    • 12.2.6. Others
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Trisomy
    • 12.3.2. Micro-deletions Symptoms
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Technology, 2017-2031
    • 12.4.1. NGS
    • 12.4.2. WGS
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Diagnostic Laboratories
    • 12.5.3. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Test Type
    • 12.7.2. By Application
    • 12.7.3. By Technology
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Non-invasive Prenatal Testing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Test Type, 2017-2031
    • 13.2.1. Materni21
    • 13.2.2. Harmony
    • 13.2.3. Panorama
    • 13.2.4. Verifi
    • 13.2.5. NIFTY
    • 13.2.6. Others
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Trisomy
    • 13.3.2. Micro-deletions Symptoms
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Technology, 2017-2031
    • 13.4.1. NGS
    • 13.4.2. WGS
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Diagnostic Laboratories
    • 13.5.3. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Test Type
    • 13.7.2. By Application
    • 13.7.3. By Technology
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Non-invasive Prenatal Testing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Test Type, 2017-2031
    • 14.2.1. Materni21
    • 14.2.2. Harmony
    • 14.2.3. Panorama
    • 14.2.4. Verifi
    • 14.2.5. NIFTY
    • 14.2.6. Others
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Trisomy
    • 14.3.2. Micro-deletions Symptoms
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Technology, 2017-2031
    • 14.4.1. NGS
    • 14.4.2. WGS
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Diagnostic Laboratories
    • 14.5.3. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Test Type
    • 14.7.2. By Application
    • 14.7.3. By Technology
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Non-invasive Prenatal Testing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Test Type, 2017-2031
    • 15.2.1. Materni21
    • 15.2.2. Harmony
    • 15.2.3. Panorama
    • 15.2.4. Verifi
    • 15.2.5. NIFTY
    • 15.2.6. Others
  • 15.3. Market Value Forecast, by Application, 2017-2031
    • 15.3.1. Trisomy
    • 15.3.2. Micro-deletions Symptoms
    • 15.3.3. Others
  • 15.4. Market Value Forecast, by Technology, 2017-2031
    • 15.4.1. NGS
    • 15.4.2. WGS
    • 15.4.3. Others
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Hospitals
    • 15.5.2. Diagnostic Laboratories
    • 15.5.3. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Test Type
    • 15.7.2. By Application
    • 15.7.3. By Technology
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by tier and size of companies)
  • 16.2. Market Share Analysis, by Company, 2021
  • 16.3. Company Profiles
    • 16.3.1. Berry Genetics
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Financial Analysis
      • 16.3.1.3. Growth Strategies
      • 16.3.1.4. SWOT Analysis
    • 16.3.2. BGI
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Financial Analysis
      • 16.3.2.3. Growth Strategies
      • 16.3.2.4. SWOT Analysis
    • 16.3.3. Laboratory Corporation of America Holdings
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Financial Analysis
      • 16.3.3.3. Growth Strategies
      • 16.3.3.4. SWOT Analysis
    • 16.3.4. Agilent Technologies, Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Financial Analysis
      • 16.3.4.3. Growth Strategies
      • 16.3.4.4. SWOT Analysis
    • 16.3.5. Illumina, Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Financial Analysis
      • 16.3.5.3. Growth Strategies
      • 16.3.5.4. SWOT Analysis
    • 16.3.6. F. Hoffmann-La Roche Ltd.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Financial Analysis
      • 16.3.6.3. Growth Strategies
      • 16.3.6.4. SWOT Analysis
    • 16.3.7. PerkinElmer, Inc.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Financial Analysis
      • 16.3.7.3. Growth Strategies
      • 16.3.7.4. SWOT Analysis
    • 16.3.8. Eurofins LifeCodexx AG
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Financial Analysis
      • 16.3.8.3. Growth Strategies
      • 16.3.8.4. SWOT Analysis
    • 16.3.9. QIAGEN
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Financial Analysis
      • 16.3.9.3. Growth Strategies
      • 16.3.9.4. SWOT Analysis
    • 16.3.10. IGENOMIX
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Financial Analysis
      • 16.3.10.3. Growth Strategies
      • 16.3.10.4. SWOT Analysis
    • 16.3.11. Pacific Biosciences
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Financial Analysis
      • 16.3.11.3. Growth Strategies
      • 16.3.11.4. SWOT Analysis
    • 16.3.12. Natera, Inc.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Financial Analysis
      • 16.3.12.3. Growth Strategies
      • 16.3.12.4. SWOT Analysis